MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 140 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,240,130 | +25.6% | 524,013 | +56.1% | 0.11% | +18.7% |
| Q2 2023 | $4,171,421 | -15.9% | 335,593 | -5.2% | 0.09% | -24.2% |
| Q1 2023 | $4,958,601 | +49.7% | 353,933 | +52.9% | 0.12% | +29.0% |
| Q4 2022 | $3,311,463 | +16.7% | 231,409 | +108.1% | 0.09% | +9.4% |
| Q3 2022 | $2,838,000 | -24.3% | 111,177 | -15.7% | 0.08% | -29.2% |
| Q2 2022 | $3,748,000 | +211.3% | 131,917 | +286.5% | 0.12% | +224.3% |
| Q1 2022 | $1,204,000 | +55.2% | 34,130 | +84.4% | 0.04% | +48.0% |
| Q4 2021 | $776,000 | +218.0% | 18,509 | +169.9% | 0.02% | +127.3% |
| Q1 2021 | $244,000 | – | 6,858 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |